Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ivabradine Monotherapy for the Treatment of Congenital Junctional Ectopic Tachycardia in a Premature Neonate

View through CrossRef
Congenital junctional ectopic tachycardia is a rare and special type of supraventricular arrhythmia. Junctional ectopic tachycardia is characterized by persistently elevated heart rates that may cause an impairment in cardiac function. Junctional ectopic tachycardia is considered one of the most difficult-to-treat conditions even with a combination of antiarrhythmic medications. Ivabradine is a novel antiarrhythmic medication used to decrease the heart rate in adults with angina pectoris. We report a first case of a premature neonate with a normal heart structure who developed junctional ectopic tachycardia and was subsequently treated successfully with ivabradine.
Title: Ivabradine Monotherapy for the Treatment of Congenital Junctional Ectopic Tachycardia in a Premature Neonate
Description:
Congenital junctional ectopic tachycardia is a rare and special type of supraventricular arrhythmia.
Junctional ectopic tachycardia is characterized by persistently elevated heart rates that may cause an impairment in cardiac function.
Junctional ectopic tachycardia is considered one of the most difficult-to-treat conditions even with a combination of antiarrhythmic medications.
Ivabradine is a novel antiarrhythmic medication used to decrease the heart rate in adults with angina pectoris.
We report a first case of a premature neonate with a normal heart structure who developed junctional ectopic tachycardia and was subsequently treated successfully with ivabradine.

Related Results

Ivabradine in the treatment of congenital junctional ectopic tachycardia: A systematic review
Ivabradine in the treatment of congenital junctional ectopic tachycardia: A systematic review
BACKGROUND Congenital junctional ectopic tachycardia (CJET) is a rare but life-threatening arrhythmia in neonates and infants, often refractory to conventional antiarrhyt...
The Effect of Ivabradine on Hospitalization of Heart Failure Patients
The Effect of Ivabradine on Hospitalization of Heart Failure Patients
Background: Ivabradine is recommended in heart failure (HF) patients to reduce cardiovascular death and hospitalization due to worsening of HF symptoms. ...
COMPARISON OF ORAL IVABRADINE AND METOPROLOL FOR CONTROL OF HEART RATE IN PATIENTS UNDERGOING CT CORONARY ANGIOGRAPHY
COMPARISON OF ORAL IVABRADINE AND METOPROLOL FOR CONTROL OF HEART RATE IN PATIENTS UNDERGOING CT CORONARY ANGIOGRAPHY
Objectives Optimisation of heart rate (HR) to limit motion artefacts is mandatory in all patients undergoing CT coronary angiography (CTCA). Despite use of β-bloc...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration
Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration
Aims.Migration of CD4-positive lymphocytes into the vessel wall is a critical step in atherogenesis. Recent data suggest that ivabradine, a selective I(f)-channel blocker, reduces ...
Inadekvát, aránytalan sinuscsomó-tachycardia: egy régi szívritmuszavar új megvilágításban (II.)
Inadekvát, aránytalan sinuscsomó-tachycardia: egy régi szívritmuszavar új megvilágításban (II.)
Összefoglaló. Bevezetés: Az inadekvát, aránytalan sinuscsomó-tachycardia a szív nomotop ingerképzési zavarával járó, nem ritka klinikai szin...

Back to Top